Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Middleware Boosts Efficiency in Lab Automation

By LabMedica International staff writers
Posted on 03 May 2012
New middleware for clinical chemistry, microbiology, and molecular biology labs improves laboratory efficiency, compliance, and quality control.

Dubbed Halia, the middleware utilizes a rule-based engine to deliver all-round control over laboratory workflow, and sample processing. More...
The new interface provides a complete web-based lab computerization system, allowing central management and connection of all analyzers through a single interface on any workstation.

Halia’s user-configurable rule-based engine enables autoverification, sample routing, and real-time clinical data capture and management for greater quality control. By supporting open automation systems and addressing issues such as regulatory compliance, workforce reductions, and enhanced quality control, Halia effectively meets the challenges facing lab managers.

Halia instrument middleware from NoemaLife (Bologna, Italy), a European provider of clinical and hospital software solutions, provides a complete lab computerization solution. Halia also provides detailed real-time data on total turnaround time (TAT)–a key performance indicator in large laboratories striving to increase throughput. Halia permits central management of all the pre-analysis, analysis, and post analysis instruments found in a modern clinical lab.

If a Laboratory Information System/Laboratory Information Management System (LIS/LIMS system) goes down, Halia’s LIS/LIMS backup module allows manual input of sample information so that analysis can continue. Manual samples are then matched to LIS/LIMS data once the connection is restored.

Andrea Chiapponi, managing director of NoemaLife SpA, commented, "In addition to laboratories looking for open middleware which is vendor independent, Halia will be of interest to IVD device vendors wanting to create turnkey solutions which include maximum LIS/LIMS connectivity. Halia’s vendor-independence also enables merging of laboratories and even hospitalswith different LIS/LIMS solutions into a seamless wide area network. For example, Halia can manage re-tests on different analyzers deployed in separate labs and coordinate specimen storage information relating to multiple locations."

Related Links:
NoemaLife



New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Specimen Radiography System
TrueView 200 Pro
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.